Works by Cheifetz, Adam S

Results: 65

Anti‐infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.

Published in:

Journal of Pediatric Gastroenterology & Nutrition, 2024, v. 78, n. 2, p. 261, doi. 10.1002/jpn3.12074

By:

Zitomersky, Naamah;
Chi, Lisa;
Liu, Enju;
Bray, Kurtis R.;
Papamichael, Konstantinos;
Cheifetz, Adam S.;
Snapper, Scott B.;
Bousvaros, Athos;
Silvester, Jocelyn A.

Publication type:

Article

Morning Salivary Cortisol Has a Positive Correlation with GAD-7 Scores in Patients with Ulcerative Colitis.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6707, doi. 10.3390/jcm13226707

By:

Castro, Cristina M.;
Mithal, Aditya;
Deyhim, Tina;
Rabinowitz, Loren G.;
Olagoke, Olawande;
Freedman, Steven D.;
Cheifetz, Adam S.;
Ballou, Sarah K.;
Papamichael, Konstantinos

Publication type:

Article

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 7132, doi. 10.3390/jcm12227132

By:

Deyhim, Tina;
Cheifetz, Adam S.;
Papamichael, Konstantinos

Publication type:

Article

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3395, doi. 10.3390/jcm12103395

By:

Roblin, Xavier;
Duru, Gérard;
Papamichael, Konstantinos;
Cheifetz, Adam S.;
Kwiatek, Sandy;
Berger, Anne-Emmanuelle;
Barrau, Mathilde;
Waeckel, Louis;
Nancey, Stephane;
Paul, Stephane

Publication type:

Article

Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5642, doi. 10.3390/jcm10235642

By:

Nones, Rodrigo Bremer;
Fleshner, Phillip R.;
Queiroz, Natalia Sousa Freitas;
Cheifetz, Adam S.;
Spinelli, Antonino;
Danese, Silvio;
Peyrin-Biroulet, Laurent;
Papamichael, Konstantinos;
Kotze, Paulo Gustavo

Publication type:

Article

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2840, doi. 10.3390/jcm9092840

By:

Papamichael, Konstantinos;
Thomas, Valerio J.;
Banty, Andrea;
Clarke, William T.;
Germansky, Katharine A.;
Flier, Sarah N.;
Feuerstein, Joseph D.;
Melmed, Gil Y.;
Cheifetz, Adam S.

Publication type:

Article

Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?

Published in:

2025

By:

Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Editorial

Colonoscopy Is Appropriately Utilized In Most Cases Following a Fair Bowel Prep.

Published in:

2014

By:

Feuerstein, Joseph D;
Leffler, Daniel A;
Cheifetz, Adam S

Publication type:

Letter to the Editor

Systematic Analysis Underlying the Quality of the Scientific Evidence and Conflicts of Interest in Gastroenterology Practice Guidelines.

Published in:

American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 11, p. 1686, doi. 10.1038/ajg.2013.150

By:

Feuerstein, Joseph D;
Gifford, Anne E;
Akbari, Mona;
Goldman, Jonathan;
Leffler, Daniel A;
Sheth, Sunil G;
Cheifetz, Adam S

Publication type:

Article

A Random Urine Test Can Identify Patients at Risk of Mesalamine Non-Adherence: A Prospective Study.

Published in:

American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 2, p. 249, doi. 10.1038/ajg.2012.419

By:

Gifford, Anne E;
Berg, Anders H;
Lahiff, Conor;
Cheifetz, Adam S;
Horowitz, Gary;
Moss, Alan C

Publication type:

Article

Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis.

Published in:

American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 1, p. 40, doi. 10.1038/ajg.2012.363

By:

Nanda, Kavinderjit S;
Cheifetz, Adam S;
Moss, Alan C

Publication type:

Article

Mycobacterium marinum: An Increasingly Common Opportunistic Infection in Patients on Infliximab.

Published in:

American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 8, p. 1268, doi. 10.1038/ajg.2012.118

By:

Ferreira, Jason;
Grochowsky, Jared;
Krakower, Douglas;
Zuromskis, Peter;
Baden, Rachel;
Cheifetz, Adam S

Publication type:

Article

Vaccination in Inflammatory Bowel Disease.

Published in:

2011

By:

Cullen, Garret;
Baden, Rachel P.;
Cheifetz, Adam S.

Publication type:

Letter

Capsule Endoscopy in Suspected Crohn's Disease: “Yield” Does Not Equal “Diagnosis”.

Published in:

2010

By:

Doherty, Glen A.;
Moss, Alan C.;
Cheifetz, Adam S.

Publication type:

Letter

The Utility of Capsule Endoscopy in Patients With Suspected Crohn's Disease.

Published in:

American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 11, p. 2734, doi. 10.1038/ajg.2009.404

By:

Tukey, Melissa;
Pleskow, Doug;
Legnani, Peter;
Cheifetz, Adam S.;
Moss, Alan C.

Publication type:

Article

Response to Dr. Spada and Colleagues.

Published in:

2007

By:

Cheifetz, Adam S.;
Kornbluth, Asher A.;
Legnani, Peter;
Lewis, Blair S.

Publication type:

Letter

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease.

Published in:

American Journal of Gastroenterology (Springer Nature), 2006, v. 101, n. 10, p. 2218, doi. 10.1111/j.1572-0241.2006.00761.x

By:

Cheifetz, Adam S.;
Kornbluth, Asher A.;
Legnani, Peter;
Schmelkin, Ira;
Brown, Alphonso;
Lichtiger, Simon;
Lewis, Blair S.

Publication type:

Article

Editorial: is there a role for monitoring intermediate anti‐TNF drug concentrations in IBD?

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 1049, doi. 10.1111/apt.16889

By:

Rakowsky, Shana;
Cheifetz, Adam S.;
Papamichael, Konstantinos

Publication type:

Article

Letter: is blindly stopping thiopurines without confirming adequate anti‐TNF concentrations shortsighted?

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 7, p. 887, doi. 10.1111/apt.16819

By:

Sousa Freitas Queiroz, Natália;
Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Article

Review article: emerging drug therapies in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 7, p. 789, doi. 10.1111/apt.16785

By:

Grossberg, Laurie B.;
Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Article

Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.

Published in:

2021

By:

Rakowsky, Shana;
Cheifetz, Adam S.;
Papamichael, Konstantinos

Publication type:

Case Study

Editorial: real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn's disease—results from the ENEIDA registry.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 5, p. 599, doi. 10.1111/apt.15405

By:

Frasca, Joseph D.;
Cheifetz, Adam S.

Publication type:

Article

CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease.

Published in:

European Journal of Immunology, 2012, v. 42, n. 11, p. 3062, doi. 10.1002/eji.201242623

By:

Doherty, Glen A.;
Bai, Aiping;
Hanidziar, Dusan;
Longhi, Maria S.;
Lawlor, Garrett O.;
Putheti, Prabhakar;
Csizmadia, Eva;
Nowak, Martina;
Cheifetz, Adam S.;
Moss, Alan C.;
Robson, Simon C.

Publication type:

Article

Varicella Zoster Virus Infection in Patients with Inflammatory Bowel Disease.

Published in:

Gastroenterology & Hepatology, 2013, v. 9, n. 1, p. 56

By:

Ham, Maggie;
Cullen, Garret;
Cheifetz, Adam S.

Publication type:

Article

Bone of Contention: Helicobacter pylori and Osteoporosis-Is There an Association?

Published in:

2019

By:

Papamichael, Konstantinos;
Papaioannou, Garyfallia;
Cheifetz, Marcy A.;
Cheifetz, Adam S.

Publication type:

journal article

Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy.

Published in:

2019

By:

Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Editorial

Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease.

Published in:

2018

By:

Juncadella, Anna;
Papamichael, Konstantinos;
Vaughn, Byron P.;
Cheifetz, Adam S.

Publication type:

journal article

Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.

Published in:

2018

By:

Papamichael, Konstantinos;
Vajravelu, Ravy K.;
Osterman, Mark T.;
Cheifetz, Adam S.

Publication type:

journal article

Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.

Published in:

2018

By:

Feuerstein, Joseph D.;
Papamichael, Konstantinos;
Popejoy, Sara;
Nadelson, Adam;
Lewandowski, Jeffrey J.;
Geissler, Kathy;
Martinez-Vazquez, Manuel;
Leffler, Daniel A.;
Ariyabuddhiphongs, Kim;
Thukral, Chandrashekhar;
Cheifetz, Adam S.

Publication type:

journal article

Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.

Published in:

2017

By:

Feuerstein, Joseph;
Sehgal, Priya;
Rao, Varun;
Malladi, Vijayram;
Baroni, Emily;
Cheifetz, Adam;
Feuerstein, Joseph D;
Malladi, Vijayram Reddy;
Cheifetz, Adam S

Publication type:

journal article

Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.

Published in:

2016

By:

Feuerstein, Joseph;
Castillo, Natalia;
Akbari, Mona;
Belkin, Edward;
Lewandowski, Jeffrey;
Hurley, Christine;
Lloyd, Samuel;
Leffler, Daniel;
Cheifetz, Adam;
Feuerstein, Joseph D;
Castillo, Natalia E;
Lewandowski, Jeffrey J;
Hurley, Christine M;
Leffler, Daniel A;
Cheifetz, Adam S

Publication type:

journal article

Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.

Published in:

2010

By:

Moss, Alan;
Kim, Kyung;
Fernandez-Becker, Nielsen;
Cury, Didia;
Cheifetz, Adam;
Moss, Alan C;
Kim, Kyung Jo;
Cheifetz, Adam S

Publication type:

journal article

Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn's disease.

Published in:

Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03913-9

By:

Vuerich, Marta;
Wang, Na;
Graham, Jonathon J.;
Gao, Li;
Zhang, Wei;
Kalbasi, Ahmadreza;
Zhang, Lina;
Csizmadia, Eva;
Hristopoulos, Jason;
Ma, Yun;
Kokkotou, Efi;
Cheifetz, Adam S.;
Robson, Simon C.;
Longhi, Maria Serena

Publication type:

Article

Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis.

Published in:

Annals of Gastroenterology, 2016, v. 29, n. 3, p. 341, doi. 10.20524/aog.2016.0032

By:

Feuerstein, Joseph D.;
Akbari, Mona;
Tapper, Elliot B.;
Cheifetz, Adam S.

Publication type:

Article

Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities – a Workshop Report.

Published in:

AAPS Journal, 2025, v. 27, n. 2, p. 1, doi. 10.1208/s12248-025-01050-9

By:

Shubow, Sophie;
Gunsior, Michele;
Rosenberg, Amy;
Wang, Yow-Ming;
Altepeter, Tara;
Guinn, Daphne;
Rajabiabhari, Mohsen;
Kotarek, Joseph;
Mould, Diane R.;
Zhou, Honghui;
Cheifetz, Adam S.;
Garces, Sandra;
Chevalier, Rachel;
Gavan, Sean;
Trusheim, Mark R.;
Rispens, Theo;
Bray, Kurtis;
Partridge, Michael A.

Publication type:

Article

Management of Active Crohn Disease.

Published in:

JAMA: Journal of the American Medical Association, 2013, v. 309, n. 20, p. 2150, doi. 10.1001/jama.2013.4466

By:

Cheifetz, Adam S.

Publication type:

Article

Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.

Published in:

2025

By:

Owings, Anna H.;
Glover, Sarah C.;
Cheifetz, Adam S.;
Papamichael, Konstantinos

Publication type:

Letter

Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.

Published in:

Digestive Diseases & Sciences, 2024, v. 69, n. 8, p. 2796, doi. 10.1007/s10620-024-08514-6

By:

Abadir, Alexander;
Troia, Angela;
Said, Hyder;
Tarugu, Spurthi;
Billingsley, Benjamin C.;
Sairam, Nathan;
Minchenberg, Scott B.;
Owings, Anna H.;
Parker, Adam M.;
Brousse, Brandon;
Carlyle, Alexander;
Owens, Bobby R.;
Hosseini-Carroll, Pegah;
Galeas-Pena, Michelle;
Frasca, Joseph;
Glover, Sarah C.;
Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Article

Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.

Published in:

2022

By:

Syal, Gaurav;
Sparrow, Miles P.;
Velayos, Fernando;
Cheifetz, Adam S.;
Devlin, Shane;
Irving, Peter M.;
Kaplan, Gilaad G.;
Raffals, Laura E.;
Ullman, Thomas;
Gecse, Krisztina B.;
Fleshner, Phillip R.;
Lightner, Amy L.;
Siegel, Corey A.;
Melmed, Gil Y.

Publication type:

journal article

Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.

Published in:

Digestive Diseases & Sciences, 2022, v. 67, n. 1, p. 252, doi. 10.1007/s10620-021-06884-9

By:

Llanos-Chea, Alejandro;
Shapiro, Jason M.;
Winter, Rachel W.;
Jerger, Logan;
Menz, Timothy;
Gibson, Meghan;
Friedmann, Alison M.;
Treaba, Diana;
Papamichael, Konstantinos;
Cheifetz, Adam S.;
Friedman, Sonia;
Hamilton, Matthew J.;
Winter, Harland S.

Publication type:

Article

Going Beyond a Treat-To-Target to a Treat-To-Clear and a Treat-To-Trough Therapeutic Strategy in Patients with Inflammatory Bowel Disease?

Published in:

Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 825, doi. 10.1093/ecco-jcc/jjad014

By:

Queiroz, Natália Sousa Freitas;
Cheifetz, Adam S;
Papamichael, Konstantinos

Publication type:

Article

A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease.

Published in:

Journal of Crohn's & Colitis, 2023, v. 17, n. 4, p. 633, doi. 10.1093/ecco-jcc/jjac164

By:

Barrau, Mathilde;
Duprat, Manon;
Veyrard, Pauline;
Tournier, Quentin;
Williet, Nicolas;
Phelip, Jean Marc;
Waeckel, Louis;
Cheifetz, Adam S;
Papamichael, Konstantinos;
Roblin, Xavier;
Paul, Stephane

Publication type:

Article

Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?

Published in:

Journal of Crohn's & Colitis, 2021, v. 15, n. 11, p. 1785, doi. 10.1093/ecco-jcc/jjab091

By:

Gianotti, Robert J;
Cheifetz, Adam S

Publication type:

Article

Proactive Adalimumab Monitoring in Inflammatory Bowel Disease: Current Data and Future Perspectives.

Published in:

Journal of Crohn's & Colitis, 2020, v. 14, n. 6, p. 878, doi. 10.1093/ecco-jcc/jjz191

By:

Papamichael, Konstantinos;
Cheifetz, Adam S

Publication type:

Article

The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.

Published in:

Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1217, doi. 10.1093/ecco-jcc/jjz038

By:

Sands, Bruce E;
Cheifetz, Adam S;
Nduaka, Chudy I;
Quirk, Daniel;
Wang, Wenjin;
Maller, Eric;
Friedman, Gary S;
Su, Chinyu;
Higgins, Peter D R

Publication type:

Article

Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease.

Published in:

Journal of Crohn's & Colitis, 2019, v. 13, n. 8, p. 976, doi. 10.1093/ecco-jcc/jjz018

By:

Papamichael, Konstantinos;
Juncadella, Anna;
Wong, Danny;
Rakowsky, Shana;
Sattler, Lindsey A;
Campbell, James P;
Vaughn, Byron P;
Cheifetz, Adam S

Publication type:

Article

Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease.

Published in:

Journal of Crohn's & Colitis, 2018, v. 12, n. 7, p. 804, doi. 10.1093/ecco-jcc/jjy039

By:

Papamichael, Konstantinos;
Vajravelu, Ravy K.;
Vaughn, Byron P.;
Osterman, Mark T.;
Cheifetz, Adam S.

Publication type:

Article

Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.

Published in:

Journal of Crohn's & Colitis, 2017, v. 11, n. 9, p. 1113, doi. 10.1093/ecco-jcc/jjx058

By:

Feldbrügge, Linda;
Moss, Alan C.;
Yee, Eric U.;
Csizmadia, Eva;
Mitsuhashi, Shuji;
Serena Longhi, Maria;
Sandhu, Bynvant;
Stephan, Holger;
Yan Wu;
Cheifetz, Adam S.;
Müller, Christa E.;
Sévigny, Jean;
Robson, Simon C.;
Jiang, Z. Gordon

Publication type:

Article

Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn's Disease.

Published in:

Journal of Crohn's & Colitis, 2016, v. 10, n. 5, p. 507, doi. 10.1093/ecco-jcc/jjw041

By:

Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Article

Infliximab in inflammatory bowel disease.

Published in:

Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319838443

By:

Papamichael, Konstantinos;
Lin, Steve;
Moore, Matthew;
Papaioannou, Garyfallia;
Sattler, Lindsey;
Cheifetz, Adam S.

Publication type:

Article